乳腺癌放疗的心脏剂量与风险:现代放疗及社区实践分析
该研究分析了2012至2014年间94个中心1161例左侧乳腺癌辅助放疗患者,中位心脏平均剂量为2.76 Gy,不同放疗技术间心脏剂量差异显著。基于该剂量估算,60岁无心血管危险因素女性80岁时归因于放疗的缺血性心脏病死亡超额风险为每1000例3.5例,总体心脏毒性风险适中。
要点
- 现代乳腺癌放疗中位心脏平均剂量为2.76 Gy,技术选择显著影响剂量。
- 深吸气屏气较自由呼吸降低预测中位心脏剂量(2.41 Gy vs 3.86 Gy)。
- 三维适形放疗的心脏剂量低于固定机架调强和旋转调强放疗。
核心结论
- 在 predominantly 社区实践中,乳腺癌放疗的心脏平均剂量随患者和技术差异较大,但总体心脏毒性风险适中。
研究设计与样本
- 回顾性队列研究,纳入2012至2014年间16个州94个中心的1161例左侧乳腺癌辅助放疗女性。
- 采用双变量分析和多变量线性回归评估放疗技术与心脏平均剂量的关联。
- 基于既往报告的心脏平均剂量与心脏风险关系,估算60岁诊断女性80岁时的放疗相关超额心脏风险。
主要发现
- 77.3%的患者在社区实践接受治疗,77.8%接受保乳治疗。
- 最常见技术为自由呼吸(92.2%)、仰卧位(94.8%)和固定机架调强放疗(46.9%)。
- 中位心脏平均剂量为2.76 Gy(四分位距1.47-5.03 Gy)。
- 多变量分析中,深吸气屏气预测中位心脏平均剂量为2.41 Gy,自由呼吸为3.86 Gy(P < .001)。
- 三维适形放疗预测中位心脏平均剂量为2.78 Gy,低于固定机架调强(4.02 Gy)和旋转调强(6.60 Gy),P < .001。
关键数值与推荐
- 60岁无心血管危险因素女性,心脏平均剂量2.76 Gy时,20年预测归因于放疗的缺血性心脏病死亡超额风险为每1000例3.5例超额事件。
- 既往分析估计的相应风险为每1000例8例事件。
- 预测心脏事件风险随技术变化:三维适形放疗每1000例4例超额事件,固定机架调强每1000例5例,旋转调强每1000例8例。
临床怎么用
- 临床选择放疗技术时应考虑心脏剂量,优先选择能降低心脏平均剂量的技术如深吸气屏气和三维适形放疗。
- 对左侧乳腺癌患者,尤其需关注心脏剂量评估,以个体化权衡心脏毒性风险。
局限性
- 心脏风险为基于既往关系的预测估算,非直接观察结局。
- 研究为回顾性设计,可能受混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Adjuvant radiation therapy (RT) for breast cancer improves outcomes, but prior studies have documented substantive cardiac dose and cardiac risk. We assessed the mean heart dose (MHD) of RT and estimated the risk of RT-associated cardiac toxicity in women undergoing adjuvant RT for breast cancer in contemporary (predominantly) community practice. METHODS AND MATERIALS: We identified women with left-sided breast cancer receiving adjuvant RT between 2012 and 2014 from 94 centers across 16 states. We used bivariate analyses and multivariable linear regression to assess associations between RT techniques and MHD. Excess RT-related cardiac risk by age 80 was estimated for women diagnosed at age 60 using the previously reported relationship between MHD and cardiac risk. RESULTS: Among 1161 women, 77.3% were treated in community practice and with breast conservation (77.8%). The most common techniques were free-breathing (92.2%), supine (94.8%), and fixed gantry intensity modulated RT (FG-IMRT; 46.9%). The median MHD was 2.76 Gy (interquartile range, 1.47-5.03). In multivariable analyses, the predicted median MHD with deep inspiration breath hold was 2.41 Gy compared with 3.86 Gy with free-breathing (P < .001). Three-dimensional conformal RT (3D-CRT) was associated with a lower predicted median MHD (2.78 Gy) than FG-IMRT (4.02 Gy) or rotational IMRT, 6.60 Gy, P < .001). For 60-year-old women with the median MHD of the study population (2.76 Gy) and no cardiovascular risk factors, the 20-year predicted excess risk of death from ischemic heart disease attributable to radiation was 3.5 excess events/1000 patients, in contrast to estimates of 8 events/1000 from prior analyses. The predicted risk of cardiac events varied based on radiation technique, with 4 excess events/1000 with 3D-CRT, 5 excess events/1000 with FG-IMRT, and 8 excess events/1000 with rotational IMRT. CONCLUSIONS: MHD varies substantially across patients and is influenced by technique in predominantly community settings. Overall risk of cardiac toxicity is modest.
引用
- Hong JC, Rahimy E, Gross CP, et al. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. Pract Radiat Oncol. 2017. PMID: 28888675. doi:10.1016/j.prro.2017.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。